Evidence map›Paper›PMID 39358428›Full record

ArticleScientific reports2024

Deep learning-derived optimal aviation strategies to control pandemics.

Syed Rizvi, Akash Awasthi, Maria J Peláez, Zhihui Wang, Vittorio Cristini, Hien Van Nguyen, Prashant Dogra

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Syed Rizvi *Department of Computer Science, Yale University, New Haven, CT, 06511, USA.
Akash Awasthi *Department of Electrical and Computer Engineering, University of Houston, Houston, TX, 77004, USA.
Maria J PeláezMathematics in Medicine Program, Department of Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Zhihui WangMathematics in Medicine Program, Department of Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Vittorio CristiniMathematics in Medicine Program, Department of Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Hien Van NguyenDepartment of Electrical and Computer Engineering, University of Houston, Houston, TX, 77004, USA.
Prashant DograMathematics in Medicine Program, Department of Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA. pdogra@houstonmethodist.org.

Funding

The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular CarcinomaP50CA217674 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BERETTA, LAURA, KASEB, AHMED · 2019 to 2023
$11.3M
Ultra-long Acting Transcutaneously Refillable Islatravir Nanofluidic Implant for HIV Pre-ExposureR01AI165372 · NIAID · METHODIST HOSPITAL RESEARCH INSTITUTE · PI GRATTONI, ALESSANDRO · 2022 to 2025
$4.5M
A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate CancerR01CA226537 · NCI · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI ARAP, WADIH, BRINKER, C JEFFREY · 2018 to 2022
$3.2M
Vascularized Islet transplantation NICHE with local immunosuppression for the treatment of type 1 diabetesR01DK132104 · NIDDK · METHODIST HOSPITAL RESEARCH INSTITUTE · PI GRATTONI, ALESSANDRO, NICHOLS, JOAN ELIZABETH · 2022 to 2025
$2.8M
miR-155 targeted therapeutics for precision medicine in lung cancerR01CA222007 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CALIN, GEORGE A., CRISTINI, VITTORIO · 2018 to 2022
$2.6M
Nanoparticle delivery of miRNA-based therapeutics to overcome clinical challenges in triple negative breast cancerR01CA253865 · NCI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI OZPOLAT, BULENT, WANG, ZHIHUI · 2021 to 2025
$2.0M
Physiologically Based Pharmacokinetic Modeling of Silica NanoparticlesR03EB033576 · NIBIB · UNIVERSITY OF UTAH · PI YELLEPEDDI, VENKATA K · 2022 to 2023
$162k
NCI NIH HHS P50 CA217674NCI NIH HHS R01 CA222007NCI NIH HHS R01 CA226537NCI NIH HHS R01 CA253865NIAID NIH HHS R01 AI165372NIBIB NIH HHS R03 EB033576NIDDK NIH HHS R01 DK132104
6 · The paper itself

Abstract

The COVID-19 pandemic affected countries across the globe, demanding drastic public health policies to mitigate the spread of infection, which led to economic crises as a collateral damage. In this work, we investigate the impact of human mobility, described via international commercial flights, on COVID-19 infection dynamics on a global scale. We developed a graph neural network (GNN)-based framework called Dynamic Weighted GraphSAGE (DWSAGE), which operates over spatiotemporal graphs and is well-suited for dynamically changing flight information updated daily. This architecture is designed to be structurally sensitive, capable of learning the relationships between edge features and node features. To gain insights into the influence of air traffic on infection spread, we conducted local sensitivity analysis on our model through perturbation experiments. Our analyses identified Western Europe, the Middle East, and North America as leading regions in fueling the pandemic due to the high volume of air traffic originating or transiting through these areas. We used these observations to propose air traffic reduction strategies that can significantly impact controlling the pandemic with minimal disruption to human mobility. Our work provides a robust deep learning-based tool to study global pandemics and is of key relevance to policymakers for making informed decisions regarding air traffic restrictions during future outbreaks.

Indexed as

AviationCOVID-19Deep LearningPandemicsHumansNeural Networks, ComputerSARS-CoV-2Artificial intelligenceAviation policyCOVID-19Deep learningGraph neural networkPandemic

Identifiers

PMID39358428
PMCPMC11447252

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.